GTR 101065591
Bids Are Invited For Lipase + Amylase + Protease (25.000Ui + 74.700Ui + 62.500Ui) Cap, Lanreotide 120 Mg Sol Inj Syringe 0.5 Ml, Meropenem 500 Mg Sol Inj Fa Iv, Bleomycin (Sulfate) 15 Mg Lyophilized Powder For Sun Inj Fa, Nilotinib 200Mg Capsule, Doxorrubicine Liposomal 2Mg/Ml Ampoule 10 Ml Vial, Dasatinib 100 Mg Tablet, Immuno Bcg 40Mg Ampoule Flask, Immuno Bcg 40Mg Ampoule Bottle, Lorlatinib 100 Mg Coated Tablet
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
101065591
Tendering Authority
Subscribe to view
Tender No
90733/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Lipase + Amylase + Protease (25.000Ui + 74.700Ui + 62.500Ui) Cap, Lanreotide 120 Mg Sol Inj Syringe 0.5 Ml, Meropenem 500 Mg Sol Inj Fa Iv, Bleomycin (Sulfate) 15 Mg Lyophilized Powder For Sun Inj Fa, Nilotinib 200Mg Capsule, Doxorrubicine Liposomal 2Mg/Ml Ampoule 10 Ml Vial, Dasatinib 100 Mg Tablet, Immuno Bcg 40Mg Ampoule Flask, Immuno Bcg 40Mg Ampoule Bottle, Lorlatinib 100 Mg Coated Tablet
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
08-09-2025
Closed
Work Detail
Lipase + Amylase + Protease (25.000Ui + 74.700Ui + 62.500Ui) Cap, Lanreotide 120 Mg Sol Inj Syringe 0.5 Ml, Meropenem 500 Mg Sol Inj Fa Iv, Bleomycin (Sulfate) 15 Mg Lyophilized Powder For Sun Inj Fa, Nilotinib 200Mg Capsule, Doxorrubicine Liposomal 2Mg/Ml Ampoule 10 Ml Vial, Dasatinib 100 Mg Tablet, Immuno Bcg 40Mg Ampoule Flask, Immuno Bcg 40Mg Ampoule Bottle, Lorlatinib 100 Mg Coated Tablet. Pancreatic Enzymes, Lanreotide Acetate, Meropenem, Bleomycin Sulfate, Nilotinib, Doxorrubicin Hydrochloride, Dasatinib, Vaccine, Vandetanib, Lorlatinib
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
d7fb50a1-0702-4751-b8c9-28f62e074c53.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.